Thirty-seven percent of women prefer to receive their lifetime risk of breast cancer through numbers and words, while 73% prefer a combination of lifetime and 10-year age-related risk.
As part of the BRISC (Breast cancer RIsk Communication study) study out of the Netherlands, investigators sought to determine if method of delivery and personal preference affected how women understood their lifetime risk of breast cancer. Both of these are deemed essential to improving patient-centered care. Their results were published in a recent issue of Patient Preference and Adherence.
“Effective risk communication is a major challenge because many counselees find it difficult to understand the concept of risk,” the study authors stated. “Moreover, the increasing development and use of risk stratification models will make breast cancer risk communication become even more important.”
Their study addressed 3 important questions:
The 326 women, who were recruited from 3 family cancer clinics in the Netherlands between December 2005 and November 2007, had a family history of breast cancer but had not battled the disease. Their mean (SD) age was 41 (11) years, and 25% were classified as high-risk (30%-40% risk of developing breast cancer).
A counselor presented the risk information to the women following a genetic counseling session. They received this information in 1 of 5 ways:
Two weeks later, the women were asked to fill out a questionnaire. Eighty-six percent (279/326) of the women complied, and they demonstrated a strong grasp of the information they received. These results showed that when receiving their lifetime risk, 37%, the overwhelming majority, preferred to receive their lifetime risk of breast cancer through numbers and words; that when given the choice between percentages and frequencies, 55% chose the former; and that the top choice, at 73%, for time frame was a combination of lifetime and 10-year age-related risk.
In addition, women who were presented with their risk though a graphical display preferred that format. The authors attributed this to figures being “easy to identify with, understandable, and [they] conveyed a meaningful message.” And more older women preferred the 10-year age-related format, which the authors believe is because “the residual risk diminishes with age and thus more specific age-related risks may be preferred by this older age group.”
A notable previous recommendation for how to deliver this information is for counselors to consider how their patients want to receive it, especially because, say the authors, women can estimate their own risk more accurately “when they receive their risk estimates in their preferred format.”
They advise that more studies are needed to investigate the influence of personal preference on understanding and decision-making following receipt of lifetime breast cancer risk.
Reference
Henneman L, van Asperen CJ, Oosterwijk JC, Menko FH, Claassen L, Timmermans DRM. Do preferred risk formats lead to better understanding? a multicenter controlled trial on communicating familial breast cancer risks using different risk formats. Patient Prefer Adherence. 2019;14:333-342. doi: 10.2147/PPA.S232941.
Racial Inequities in Guideline-Adherent Breast Cancer Care and Timely Treatment
November 19th 2024Older non-Hispanic Black adults with early-stage breast cancer are less likely to receive timely treatment and guideline-concordant care, increasing their risk of death compared with non-Hispanic White women.
Read More
Emily Goldberg Shares Insights as a Genetic Counselor for Breast Cancer Risk Screening
October 30th 2023On this episode of Managed Care Cast, Emily Goldberg, MS, CGC, a genetic counselor at JScreen, breaks down how genetic screening for breast cancer works and why it is so important to increase awareness and education around these screening tools available to patients who may be at risk for cancer.
Listen
The Disproportionate Impact of the Pandemic on Health Care Disparities and Cancer
February 22nd 2022On this episode of Managed Care Cast, we discuss how already wide health care inequities in cancer are becoming much worse because of the COVID-19 pandemic, with guest Monica Soni, MD, associate chief medical officer at New Century Health.
Listen
Advancing Breast Cancer Care With HER2-Targeted Therapies
October 10th 2024In this interview from our Institute for Value-Based Medicine® event in Boston, we speak with Michael Hassett, MD, MPH, Dana-Farber Cancer Institute, on the clinical significance and cost implications of HER2 in the breast cancer space.
Read More
Managing Germline Mutations in Hereditary Breast Cancer Risk
October 7th 2024Hereditary breast cancers are caused by germline mutations, which are genetic mutations inherited at conception and so called because they originate in germ cells, those that develop into reproductive cells and become eggs in female individuals and sperm in male individuals.
Read More